Standard Biotools Inc (LAB) earnings · rev $85.3M
These earnings events as JSON? API free 100/dayStandard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
This LAB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LAB revenue for 2025-12-31 was $85.3M. Net income was -$74.9M. Revenue was down 51.1% from 2024-12-31 to 2025-12-31. LAB currently screens at market cap $317.1M.
When the next LAB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 51.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full LAB research stays on the stock page; the tape stays on the quote page.
LAB earnings FAQ
What are LAB's latest revenue and net income?
Latest cached Standard Biotools Inc (LAB) revenue for Dec 31, 2025 was $85.3M. Net income was -$74.9M. Statements: https://lician.com/financials/lab
What is LAB's latest diluted EPS?
Latest cached Standard Biotools Inc (LAB) diluted EPS for Dec 31, 2025 was -$0.20.
What period does the latest LAB earnings print cover?
The latest cached Standard Biotools Inc (LAB) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did LAB revenue change from the prior cached period?
Cached Standard Biotools Inc (LAB) revenue was down 51.1% from $174.4M (Dec 31, 2024) to $85.3M (Dec 31, 2025). Statements: https://lician.com/financials/lab
Where are LAB earnings listed?
Cached earnings facts for Standard Biotools Inc (LAB) are listed at https://lician.com/earnings/lab. Statements: https://lician.com/financials/lab
Not investment advice.